PROM1 and hepatocellular carcinoma: This work provides a resource for understanding the impact of CD133+ CSCs (CSCs) on the progression of HCC in terms of tumor-immune interactions and has potential therapeutic and prognostic implications for identifying ways to advance immunotherapy research.